NCT03597152 is a NA clinical trial of WelTract in Recurrent Urinary Tract Infection, sponsored by AmPurity Nutraceuticals, LLC.

Who is sponsoring NCT03597152?

NCT03597152 is sponsored by AmPurity Nutraceuticals, LLC.

What drugs are being tested in NCT03597152?

Interventions in NCT03597152: WelTract, Placebo.

What condition does NCT03597152 study?

NCT03597152 studies Recurrent Urinary Tract Infection.

Is NCT03597152 still recruiting?

NCT03597152 is currently status unknown. Last updated 10 January 2020.

Last reviewed 2020-01-10 · How we verify

NCT03597152

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nutritional Supplementation for Recurrent Urinary Tract Infections in Women

Status unknown NA Last updated 10 January 2020

What this trial tests

NA trial testing WelTract in Recurrent Urinary Tract Infection in 250 participants. Status unknown.

Timeline

1 August 2020

Primary endpoint
14 January 2022

31 December 2022

Quick facts

Lead sponsor	AmPurity Nutraceuticals, LLC
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	prevention
Enrollment	250
Start date	1 August 2020
Primary completion	14 January 2022
Estimated completion	31 December 2022

Drugs / interventions tested

WelTract
Placebo

Conditions studied

Recurrent Urinary Tract Infection — all drugs for Recurrent Urinary Tract Infection →

Sponsor

AmPurity Nutraceuticals, LLC

Who can join

Adults 18 to 75, female only, with Recurrent Urinary Tract Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will test the ability of specially formulated nutritional supplement capsules to extend the time between recurrent urinary tract infections in women. This objective will be completed by enrolling women who have suffered from 3-4 uncomplicated UTIs in the past 12 months into a double blind placebo controlled cross-over trial. Cross-over and study completion are triggered by the next two UTI recurrences. The goal of the study is for the supplement to extend the time to the next UTI for study participants as compared to placebo.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Cranberries for preventing urinary tract infections.
Williams G, Hahn D, Stephens JH, Craig JC, et al · · 2023 · cited 33× · PMID 37068952 · DOI 10.1002/14651858.cd001321.pub6
D-mannose for preventing and treating urinary tract infections.
Cooper TE, Teng C, Howell M, Teixeira-Pinto A, et al · · 2022 · cited 29× · PMID 36041061 · DOI 10.1002/14651858.cd013608.pub2
Cranberries for preventing urinary tract infections.
Williams G, Stothart CI, Hahn D, Stephens JH, et al · · 2023 · cited 12× · PMID 37947276 · DOI 10.1002/14651858.cd001321.pub7
Original Article Phytotherapy in Adults With Recurrent Uncomplicated Cystitis.
Kranz J, Lackner J, Künzel U, Wagenlehner F, et al · · 2022 · cited 7× · PMID 35101170 · DOI 10.3238/arztebl.m2022.0104

Verify or expand the search:

Other recruiting trials for Recurrent Urinary Tract Infection

Currently open trials in the same condition.

NCT06940622 — A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections · NA · recruiting
NCT06124820 — RCT Comparing Intravaginal Laser Therapy to Sham in Post-menopausal Women with Recurrent Urinary Tract Infections · NA · active not recruiting
NCT06050148 — Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections · Phase 2, PHASE3 · recruiting
NCT05553652 — The Effect of ASTARTE™ on Recurrent Urinary Tract Infection · NA · recruiting
NCT04807894 — Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03597152 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by AmPurity Nutraceuticals, LLC
Last refreshed: 10 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03597152.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing